Law360, New York (January 3, 2008, 12:00 AM EST) -- The U.S. Court of Appeals for the D.C. Circuit has ruled that the U.S. Food and Drug Administration may have to cough up attorneys' fees in a long-running spat with the Campaign for Responsible Transplantation over the method of using nonhuman organs or tissue in transplants to the human body.
On Thursday, the D.C. Circuit partially reversed an earlier ruling handed down by the U.S. District Court for the District of Columbia, denying CRT's petition for an award of attorneys' fees.
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.